These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 10294299)
21. Financial impact of a home intravenous antibiotic program on a medicare managed care program. Dalovisio JR; Juneau J; Baumgarten K; Kateiva J Clin Infect Dis; 2000 Apr; 30(4):639-42. PubMed ID: 10770722 [TBL] [Abstract][Full Text] [Related]
22. A naturalistic comparison of amoxicillin/clavulanate extended release versus immediate release in the treatment of acute bacterial sinusitis in adults: A retrospective data analysis. Jackson J; Fernandes AW; Nelson W Clin Ther; 2006 Sep; 28(9):1462-71. PubMed ID: 17062318 [TBL] [Abstract][Full Text] [Related]
23. Reducing waste: a significant cost containment measure in an i.v. additive program. Coppola PA; Cassidy AP Hosp Pharm; 1987 Dec; 22(12):1215-6, 1246. PubMed ID: 10285376 [TBL] [Abstract][Full Text] [Related]
28. Cost analysis of an intensive home follow-up program for first-time post-myocardial infarction patients and their families. Robertson KA; Kayhko K Dynamics; 2001; 12(4):25-31. PubMed ID: 11845484 [TBL] [Abstract][Full Text] [Related]
29. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. Horvais V; Touzet S; François S; Bourdy S; Bellon G; Colin C; Durieu I Int J Technol Assess Health Care; 2006; 22(4):525-31. PubMed ID: 16984688 [TBL] [Abstract][Full Text] [Related]
30. A home care program for respiratory patients. Friesen H Can Hosp; 1973 Mar; 50(3):40-4. PubMed ID: 4592102 [No Abstract] [Full Text] [Related]
31. Foundation for establishing a home i.v. program. Streckfuss BL Caring; 1990 May; 9(5):18-22. PubMed ID: 10105438 [TBL] [Abstract][Full Text] [Related]
33. [Outpatient parenteral antimicrobial therapy (OPAT) in bone and joint infections]. Galpérine T; Ader F; Piriou P; Judet T; Perronne C; Bernard L Med Mal Infect; 2006 Mar; 36(3):132-7. PubMed ID: 16580802 [TBL] [Abstract][Full Text] [Related]
34. [Analysis of the cost-effectiveness relationship in the empirical treatment in patients with infections of the lower respiratory tract acquired in the community]. Bertrán MJ; Trilla A; Codina C; Carné X; Ribas J; Asenjo MA Enferm Infecc Microbiol Clin; 2000 Nov; 18(9):445-51. PubMed ID: 11149168 [TBL] [Abstract][Full Text] [Related]
36. [Home intravenous antibiotic therapy for osteomyelitis patients]. Steinmetz D; Edelstein H; Berkovits E; Raz R Harefuah; 2002 May; 141(5):439-41, 498. PubMed ID: 12073523 [TBL] [Abstract][Full Text] [Related]
37. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056 [TBL] [Abstract][Full Text] [Related]
38. A randomized trial of home vs hospital intravenous antibiotic therapy in adults with infectious diseases. Wolter JM; Cagney RA; McCormack JG J Infect; 2004 Apr; 48(3):263-8. PubMed ID: 15001305 [TBL] [Abstract][Full Text] [Related]
39. Patient-teaching program for home intravenous antimicrobial therapy. Schad RF; Lucarotti RL Am J Hosp Pharm; 1986 Feb; 43(2):372-5. PubMed ID: 3953598 [TBL] [Abstract][Full Text] [Related]
40. Case studies of pharmacy involvement in hospital-based home health care. Hamot Medical Center. Meyer JD; Brundige ML; Kelly WN Am J Hosp Pharm; 1986 Feb; 43(2):406-9. PubMed ID: 3953605 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]